Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - methoxy polyethylene glycol-epoetin beta, quantity: 0.15 mg - injection, solution - excipient ingredients: monobasic sodium phosphate monohydrate; methionine; poloxamer; sodium sulfate; mannitol; water for injections - mircera is indicated for the treatment of anaemia associated with chronic kidney disease (ckd).

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 50 mcg / 0.3 ml - methoxy polyethylene glycol-epoetin beta - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 75 mcg / 0.3 ml - methoxy polyethylene glycol-epoetin beta - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 100 mcg / 0.3 ml - methoxy polyethylene glycol-epoetin beta - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 150 mcg / 0.3 ml - methoxy polyethylene glycol-epoetin beta - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 200 mcg / 0.3 ml - methoxy polyethylene glycol-epoetin beta - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

European Union - English - EMA (European Medicines Agency)

roche registration gmbh - methoxy polyethylene glycol-epoetin beta - anemia; kidney failure, chronic - antianemic preparations - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5.1).treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.1).

Kenya - English - Pharmacy and Poisons Board

f. hoffman-la roche ltd capitol hill towerscathedral road. p.o. box - methoxy polyethylene glycol-epoetin beta - solution for injection in pre-filled syringe - methoxy polyethylene glycol-epoetin beta 120mcg - other antianemic preparations

Kenya - English - Pharmacy and Poisons Board

f. hoffman-la roche ltd capitol hill towerscathedral road. p.o. box - methoxy polyethylene glycol-epoetin beta - solution for injection/infusion in pre-filled - methoxy polyethylene glycol-epoetin beta 75mcg - other antianemic preparations

Canada - English - Health Canada

hoffmann-la roche limited - methoxy polyethylene glycol-epoetin beta - solution - 50mcg - methoxy polyethylene glycol-epoetin beta 50mcg - other antianemic preparations